Sort
30,917 grants matching “tumor microenvironment”
DNA-specific pattern recognition receptor activation following DNA electroporation
$316,169Loree C Heller · Old Dominion University · R01 · FY2017 · CA
DNA-specific pattern recognition receptor activation following DNA electroporation
$316,169Loree C Heller · Old Dominion University · R01 · FY2018 · CA
Recruitment of Stromal Cells to the Tumor Microenvironment
$316,167Robert A Weinberg · Massachusetts Institute Of Technology · U54 · FY2006 · CA
Definition of Microenvironment in Breast Cancer
$316,160Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2008 · CA
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
$316,103Denise C Connolly · Fox Chase Cancer Center · R01 · FY2011 · CA
The Role of Ubiquitin-Proteasome Pathway in Myeloma Bone Disease
$316,048Babatunde Olukayode Oyajobi · Vanderbilt University · P01 · FY2009 · CA
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy
$316,042Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy
$316,042Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2022 · CA
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$316,027Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2022 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$316,002Brian R Gastman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$316,002Brian R Gastman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.
$316,002Arnold I. Caplan · Case Western Reserve University · R01 · FY2014 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$316,002Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$316,002Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2011 · CA
EphA2 kinase in prostate cancer
$316,002Bingcheng Wang · Case Western Reserve University · R01 · FY2014 · CA
Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis
$316,002Jian Cao · State University New York Stony Brook · R01 · FY2014 · CA
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma
$316,000Pierre P Massion · Vanderbilt University Medical Center · U01 · FY2017 · CA
T Cell Unresponsiveness in Human Tumors
$315,991James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Combinatorial Vaccine Approaches for the treatment of BC
$315,989Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2010 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$315,977Tamara Levin Lotan · University Of Southern California · U19 · FY2019 · CA
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
$315,942William M Grady · Fred Hutchinson Cancer Center · U54 · FY2025 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$315,862Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2020 · CA
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
$315,831Xiaotong Song · Baylor College Of Medicine · R01 · FY2014 · CA
EVOLUTION OF INDIVIDUAL PATIENT'S TUMOR IMMUNE MICROENVIRONMENT IN THE DEVELOPMENT OF CLEAR CELL RENAL CELL CARCINOMA
$315,789The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Defense Health Agency
Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
$315,784Herbert J Zeh · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA